Astrana Health (ASTH) Common Equity (2011 - 2026)

Astrana Health's Common Equity history runs 16 years deep, the most recent figure standing at $815.2 million for Q1 2026.

• In Q1 2026, Common Equity rose 8.63% year-over-year to $815.2 million; the TTM figure through Mar 2026 stood at $815.2 million (up 8.63% YoY), while the FY2025 annual figure was $779.3 million, up 8.73% from the prior year.
• Common Equity came in at $815.2 million for Q1 2026 at Astrana Health, up from $779.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $815.2 million in Q1 2026 to a low of $472.6 million in Q1 2022.
• A 5-year average of $647.6 million and a median of $658.0 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity jumped 36.19% in 2022 and advanced 8.63% in 2026, its largest moves.
• Astrana Health's Common Equity stood at $544.3 million in 2022, then rose by 13.29% to $616.7 million in 2023, then advanced by 16.23% to $716.7 million in 2024, then increased by 8.73% to $779.3 million in 2025, then advanced by 4.61% to $815.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $815.2 million, $779.3 million, and $789.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison